Abstract # 1001 Phase 1 TITE-CRM Dose Escalation Study Of Concurrent Temozolomide And Intensity Modulated Radiation Therapy In Newly Diagnosed Glioblastoma Multiforme

Presenter: Doris Brown, MD, PhD



 Virtual Poster:
   Microsoft PowerPoint slide presentation 050002_final_1001_ASTRO_poster.ppt  (1.1M)

Poster:



E-mail a friend about this poster:
Enter email address: